Literature DB >> 29169990

Lack of Heme Oxygenase-1 Induces Inflammatory Reaction and Proliferation of Muscle Satellite Cells after Cardiotoxin-Induced Skeletal Muscle Injury.

Magdalena Kozakowska1, Katarzyna Pietraszek-Gremplewicz1, Maciej Ciesla1, Marta Seczynska1, Iwona Bronisz-Budzynska1, Paulina Podkalicka1, Karolina Bukowska-Strakova2, Agnieszka Loboda1, Alicja Jozkowicz1, Jozef Dulak3.   

Abstract

Heme oxygenase-1 (HO-1, Hmox1) regulates viability, proliferation, and differentiation of many cell types; hence, it may affect regeneration of injured skeletal muscle. Here, we injected cardiotoxin into gastrocnemius muscle of Hmox1+/+ and Hmox1-/- animals and analyzed cellular response after muscle injury, focusing on muscle satellite cells (SCs), inflammatory reaction, fibrosis, and formation of new blood vessels. HO-1 is strongly induced after muscle injury, being expressed mostly in the infiltrating leukocytes (CD45+ cells), including macrophages (F4/80+ cells). Lack of HO-1 augments skeletal muscle injury, evidenced by increased creatinine kinase and lactate dehydrogenase, as well as expression of monocyte chemoattractant protein-1, IL-6, IL-1β, and insulin-like growth factor-1. This, together with disturbed proportion of M1/M2 macrophages, accompanied by enhanced formation of arterioles, may be responsible for shift of Hmox1-/- myofiber size distribution toward larger one. Importantly, HO-1-deficient SCs are prone to activation and have higher proliferation on injury. This effect can be partially mimicked by stimulation of Hmox1+/+ SCs with monocyte chemoattractant protein-1, IL-6, IL-1β, and is associated with increased MyoD expression, suggesting that Hmox1-/- SCs are shifted toward more differentiated myogenic population. However, multiple rounds of degeneration/regeneration in conditions of HO-1 deficiency may lead to exhaustion of SC pool, and the number of SCs is decreased in old Hmox1-/- mice. In summary, HO-1 modulates muscle repair mechanisms preventing its uncontrolled acceleration.
Copyright © 2018 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29169990     DOI: 10.1016/j.ajpath.2017.10.017

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  13 in total

1.  The BACH1-HMOX1 Regulatory Axis Is Indispensable for Proper Macrophage Subtype Specification and Skeletal Muscle Regeneration.

Authors:  Andreas Patsalos; Petros Tzerpos; Laszlo Halasz; Gergely Nagy; Attila Pap; Nikolas Giannakis; Konstantina Lyroni; Vasiliki Koliaraki; Eva Pintye; Balazs Dezso; George Kollias; Charalampos G Spilianakis; Laszlo Nagy
Journal:  J Immunol       Date:  2019-08-12       Impact factor: 5.422

2.  Age-Dependent Dysregulation of Muscle Vasculature and Blood Flow Recovery after Hindlimb Ischemia in the mdx Model of Duchenne Muscular Dystrophy.

Authors:  Paulina Podkalicka; Olga Mucha; Katarzyna Kaziród; Iwona Bronisz-Budzyńska; Sophie Ostrowska-Paton; Mateusz Tomczyk; Kalina Andrysiak; Jacek Stępniewski; Józef Dulak; Agnieszka Łoboda
Journal:  Biomedicines       Date:  2021-04-27

3.  Lack of miR-378 attenuates muscular dystrophy in mdx mice.

Authors:  Paulina Podkalicka; Olga Mucha; Iwona Bronisz-Budzyńska; Magdalena Kozakowska; Katarzyna Pietraszek-Gremplewicz; Anna Cetnarowska; Urszula Głowniak-Kwitek; Karolina Bukowska-Strakova; Maciej Cieśla; Maria Kulecka; Jerzy Ostrowski; Michał Mikuła; Anna Potulska-Chromik; Anna Kostera-Pruszczyk; Alicja Józkowicz; Agnieszka Łoboda; Józef Dulak
Journal:  JCI Insight       Date:  2020-06-04

4.  Nrf2 Suppression Delays Diabetic Wound Healing Through Sustained Oxidative Stress and Inflammation.

Authors:  Min Li; Haibing Yu; Haiyan Pan; Xueqing Zhou; Qiongfang Ruan; Danli Kong; Zhigang Chu; Huawen Li; Jingwen Huang; Xiaodong Huang; Angel Chau; Weiguo Xie; Yuanlin Ding; Paul Yao
Journal:  Front Pharmacol       Date:  2019-09-20       Impact factor: 5.810

5.  miR-146a deficiency does not aggravate muscular dystrophy in mdx mice.

Authors:  Iwona Bronisz-Budzyńska; Katarzyna Chwalenia; Olga Mucha; Paulina Podkalicka; Alicja Józkowicz; Agnieszka Łoboda; Magdalena Kozakowska; Józef Dulak
Journal:  Skelet Muscle       Date:  2019-08-14       Impact factor: 4.912

Review 6.  Mechanistic Insight of Na/K-ATPase Signaling and HO-1 into Models of Obesity and Nonalcoholic Steatohepatitis.

Authors:  Rebecca Pratt; Hari Vishal Lakhani; Mishghan Zehra; Rutmann Desauguste; Sneha S Pillai; Komal Sodhi
Journal:  Int J Mol Sci       Date:  2019-12-21       Impact factor: 5.923

7.  The role of Nrf2 in acute and chronic muscle injury.

Authors:  Iwona Bronisz-Budzyńska; Magdalena Kozakowska; Paulina Podkalicka; Neli Kachamakova-Trojanowska; Agnieszka Łoboda; Józef Dulak
Journal:  Skelet Muscle       Date:  2020-12-08       Impact factor: 4.912

8.  The metabolic landscape in chronic rotator cuff tear reveals tissue-region-specific signatures.

Authors:  Cyriel Sebastiaan Olie; René van Zeijl; Salma El Abdellaoui; Arjen Kolk; Celeste Overbeek; Rob G H H Nelissen; Bram Heijs; Vered Raz
Journal:  J Cachexia Sarcopenia Muscle       Date:  2021-12-05       Impact factor: 12.910

9.  Muscle and cardiac therapeutic strategies for Duchenne muscular dystrophy: past, present, and future.

Authors:  Agnieszka Łoboda; Józef Dulak
Journal:  Pharmacol Rep       Date:  2020-07-20       Impact factor: 3.024

10.  Simvastatin does not alleviate muscle pathology in a mouse model of Duchenne muscular dystrophy.

Authors:  Olga Mucha; Paulina Podkalicka; Katarzyna Kaziród; Emilia Samborowska; Józef Dulak; Agnieszka Łoboda
Journal:  Skelet Muscle       Date:  2021-09-03       Impact factor: 4.912

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.